No Data Yet
Bristol Myers Squibb (BMY) and Elevance Health (ELV) posted notable gains, reflecting technical strength in the healthcare sector. This momentum, however, contrasts sharply with significant policy uncertainty from Washington regarding the Affordable Care Act (ACA) subsidies.
In a market dominated by mega-cap technology stocks, a select group of mid-cap companies is delivering superior returns by capitalizing on specialized, high-growth niches. These firms provide essential "picks and shovels" for major economic trends like artificial intelligence and renewable energy, offering an alternative growth narrative.